Executive summary
| Target not reached or not in line with other registries |
| Target attained |
| Indicator | Country average (population)1 | Country average (country)1 | England | Scotland | Northern Ireland | Wales |
|---|---|---|---|---|---|---|
| Stability: Percentage change (%) for all cancers (C00-C97 ex. C44) in 2020 compared with 2017-2019 | -10.3% | -10.1% | -10.2% | -9.7% | -8.0% | -12.6% |
| Registry Creep: Percentage (%) for all cancers (C00-C97 ex. C44) of 2019 registrations (extracted between 04/02/2022 and 06/05/2023) compared with registrations extracted between 22/02/2021 and 06/08/22 6. | 0.3% | -0.1% | 0.6% | -2.9% | 1.0% | 0.8% |
| Staging: Proportion (%) of all cases (C00-C97 ex. C44) with valid known stage registered out of all 2020 registered cancers (C00-C97 ex. C44)2 | 75.1% | 75.8% | 75.5% | 66.4% | 81.2% | 80.0% |
| Average of Core Patient Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with demographic information3 | 98.9% | 97.8% | 99.3% | 98.3% | 100.0% | 93.5% |
| Average of Core Tumour Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with tumour information4 | 96.4% | 96.3% | 96.5% | 96.1% | 96.3% | 96.1% |
| Diagnosing Hospital Known: Percentage (%) of all cancers (C00-C97 ex. C44) registered with an organisation of diagnosis | 96.8% | 96.8% | 96.8% | 95.5% | - | 98.1% |
| Death Certificate Only (DCO) Rates: Percentage (%) of all cancers (C00-C97 ex. C44) registered as a DCO5 | 2.1% | 1.2% | 2.3% | 0.6% | 0.9% | 0.9% |
| Zero Day Survivors: Percentage (%) of all cancers (C00-C97 ex. C44) registered with the date of death equals the date of diagnosis5 | 2.8% | 1.7% | 3.1% | 1.2% | 1.1% | 1.7% |
| Microscopically Verified: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified | 81.0% | 80.8% | 81.2% | 79.2% | 83.4% | 79.6% |
| Non Specific Codes: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified with non specific morphology codes | 1.4% | 1.1% | 1.5% | 0.9% | 1.2% | 0.9% |
| Grade: Percentage (%) of all cancers (C00-C97 ex. C44) registered with a known grade | 56.1% | 57.3% | 55.9% | 57.3% | 59.6% | 56.5% |
| Treatment: Percentage (%) of all cancers (C00-C97 ex. C44) registered with any treatment | 85.4% | 82.0% | 85.9% | 86.1% | 74.8% | 81.2% |
| Breast Screening Data: Percentage of breast cancer (C50) cases from 2019 screen detected for ages 50-64 | 50.5% | 51.4% | 50.3% | 50.4% | 49.7% | 55.1% |
| Cervical Screening Data: Percentage of cervical cancer (C53) cases from 2019 screen detected for ages 25-60 | 20.4% | 44.2% | 13.5% | 54.3% | 63.1% | 45.9% |
| Bowel Screening Data: Percentage of bowel cancer (C18-C20) cases from 2019 screen detected for ages 60-69 | 5.8% | 22.1% | 0.0% | 37.1% | 26.6% | 24.9% |
- For England, Scotland, Wales and Northern Ireland.
- Staging target: > 70%
- Core Patient information includes name, address, postcode, sex, date of birth, ethnicity, date of death, unique health identifier
- Core Tumour information includes date of diagnosis, site of primary growth, type of growth, behaviour of growth, basis of diagnosis
- DCO and zero survivor rate targets: <2%
- Extraction dates for last years indicators: England 04/09/2021, Scotland 22/02/2021, Northern Ireland 16/09/2021 & Wales 06/08/2022
Extraction dates for this years indicators: England 01/10/2022, Scotland 04/02/2022, Northern Ireland 09/02/2023, Wales 06/05/2023
Notation '-' denotes not available (average excludes corresponding country)
For England, 0.0% reflects the unavailability of screening data to NCRAS. NCRAS continued to work with the screening programme to try and obtain an extract to use to pilot a new method of loading screening data files on the Encore ‘waterfall’